Skip to content

IRF2 exacerbates diabetic neuropathic pain by promoting high glucose-induced M1 polarization through IL-6/STAT3.

Aug 2026 · Genes & Genomics · 0 citations · 38 references
Medicine

TL;DR

IRF2 exacerbates DNP by activating IL-6/STAT3 to promote HG-induced M1 macrophage polarization and Knockdown of IRF2 improved pain sensitivity in DNP mice and ameliorated sciatic nerve injury.

View source

Similar papers

Aug 2026

Mechanism of SGLT2 inhibitors in improving immune imbalance in diabetic mice with sepsis via regulating macrophage M2 polarization through the APOC1/HMGB1/TLR4 axis.

This study aimed to investigate the mechanism by which the sodium-glucose cotransporter-2 (SGLT2) inhibitor dapagliflozin improves immune imbalance in sepsis with diabetes, focusing on its regulation of macrophage M2 polarization through the APOC1/HMGB1/TLR4 axis. A mouse model of type 2 diabetes was established throug...

Ting-Ting You, Huo-Bao Yang, Gang Chen · 0 citations
Aug 2026

Downregulation of miR-33a-5p regulates TNF-α/NF-κB signaling and is associated with reduced diabetic neuropathic pain through targeting SIRT6.

BACKGROUND The pathogenesis of diabetic neuropathic pain (DNP) remains unclear, with neuroinflammation mediated by abnormal TNF-α/NF-κB pathway activation being a key factor. This study aims to elucidate how this pathway contributes to DNP. METHODS miR-33a-5p levels were measured via qPCR in the serum of diabetic pat...

Wenjun Li, Yimei Li, Yong-Xin Wang · 0 citations
Open access Aug 2026

FOXO4 enhances high glucose-induced HK-2 cell damage and inflammation by targeting TFPI2 in diabetic nephropathy.

FOXO4 promotes HG-induced HK-2 cell damage and inflammation via regulating TFPI2 in vitro and alleviates renal injury and inflammation in vivo, and TFPI2 knockdown alone alleviates renal injury and inflammation in vivo.

Liqin Mu, Yu Zhao, Yang Li et al. · 0 citations
Open access Sep 2026

Macrophage FOXO1 Inhibition Protects Against Hyperglycaemia‐Associated Kidney Injury

Diabetic kidney disease (DKD) is one of the most significant microvascular complications of diabetes, characterized by high incidence and mortality; however, its pathogenesis remains unclear. Renal inflammation and macrophage infiltration play pivotal roles in driving DKD progression. The transcription factor forkhead...

He-Jie Zhu, Qian Liu, Lun-Qiang Yang et al. · 0 citations
Open access Sep 2026

JQ-1 attenuates microglial activation and retinal pathology in experimental diabetic retinopathy with modulation of Pagr1a/JAK2/STAT3 signaling.

Findings support a BRD4-associated Pagr1a/JAK2/STAT3 regulatory mechanism in diabetic retinal inflammation and identify Pagr1a as a candidate therapeutic target for further investigation.

Ran Wang, Li-Wen Wang, Xu Sun et al. · 0 citations
Open access Aug 2026

Empagliflozin attenuates AGE-BSA/high-glucose-induced inflammation in C2C12 myotubes associated with suppression of the RAGE/NF-κB pathway

Empagliflozin attenuates AGE-BSA/high-glucose-induced inflammatory injury in C2C12 myotubes, and this effect is associated with reduced activation of RAGE/NF-κB-related inflammatory signaling.

Xiao-Ying Zhang, Yu Mao, Jia-Xing Wu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.